Xeris Biopharma Holdings Inc (XERS) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Xeris Biopharma Holdings Inc 's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.62 in the third quarter 2026Average processing period, for Xeris Biopharma Holdings Inc 's inventories remained unchanged at 589 days, in the Sep 30 2026 quarter.

Within Healthcare sector 344 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 1628.

XERS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Xeris Biopharma Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 14.03 % 20.28 % 40.89 % 42.55 % 49.52 %
Y / Y Cost of Sales Growth 13.03 % 5.16 % 21.15 % 15.5 % -19.11 %
Inventory Turnover Ratio (TTM) 0.62 0.62 0.64 0.66 0.7
XERS's Total Ranking # 1628 # 1628 # 1143 # 1182 #
Average inventory processing period 591 590 570 549 523
Seq. Inventory Growth -4.95 % 9.02 % 8.1 % 1.8 % 0.27 %
Seq. Cost of Sales Growth -0.66 % 18.33 % -3.41 % -0.45 % -7.58 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 345
Overall Market # 1628

Inventory Turnover Ratio Statistics
High Average Low
2.02 0.98 0.62
(Sep 30 2020)   (Jun 30 2026)



XERS Company Profile >> Back to XERS Efficiency Comparisons >> Compare XERS Inventory Turnover Ratio to its Competitors

Financial Statements
Xeris Biopharma Holdings Inc 's Inventories $ 77 Millions Visit XERS's Balance sheet
Xeris Biopharma Holdings Inc 's Cost of Revenues TTM $ 46 Millions Visit XERS's Income Statement
What are XERS's Sales? Visit XERS's Sales by Segment

Other Inventory Turnover Ratios
Xeris Biopharma Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XERS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XERS's Competitors
Inventory Turnover Ratio for XERS's Suppliers
Inventory Turnover Ratio for XERS's Customers

You may also want to know
XERS's Sales Growth Rates XERS's Pe Price to earnings ratio XERS's Receivables Turnover Ratio XERS's Stock Quote
XERS's Net Income Growth Rates XERS's Ps Price to Sales ratio XERS's Sales per Employee XERS's Asset Turnover Ratio
XERS's Net Margin XERS's Pb Price to Book ratio XERS's Financial Strength Ratios XERS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Ocular Therapeutix Inc   1.66 $ 6.389  Millions$ 4  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions
Bio rad Laboratories Inc   1.64 $ 1,264.000  Millions$ 769  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Sanuwave Health Inc   1.54 $ 9.845  Millions$ 6  Millions
Humacyte Inc   1.53 $ 13.780  Millions$ 9  Millions
Waters Corporation  1.51 $ 1,797.864  Millions$ 1,192  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Hyperfine Inc   1.28 $ 8.502  Millions$ 7  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Lensar Inc   1.22 $ 28.813  Millions$ 24  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Mannkind Corporation  1.16 $ 51.332  Millions$ 44  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Teleflex Incorporated  1.12 $ 427.166  Millions$ 380  Millions
Acadia Pharmaceuticals Inc   1.12 $ 114.422  Millions$ 102  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions

Date modified: 2026-11-07T13:26:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.